文献速递冠心病心力衰竭与心肌病

锰增强磁共振成像在心肌中的应用

Manganese-enhanced MRI of the myocardium.
PubMed 文献 · Heart · 2019-07-23

锰增强磁共振成像(MEMRI)利用锰作为钙类似物实现心肌细胞内对比成像,可识别存活心肌。临床制剂通过螯合或与钙剂共给药降低心肌抑制风险。临床数据提示MEMRI在缺血性心肌病存活心肌定量、心肌钙处理异常早期检测及新疗法开发方面具有潜力。

要点

  • MEMRI通过锰的钙类似物特性实现心肌细胞内对比成像,可识别功能心肌。
  • 锰的早期应用受心肌抑制潜力限制,临床制剂采用螯合或与钙剂共给药克服。
  • 临床数据提示MEMRI在缺血性心肌病存活心肌定量和钙处理异常早期检测中有潜力。

核心结论

  • MEMRI作为互补性细胞内心肌对比成像方法,在存活心肌定量和钙处理异常检测方面展现临床转化潜力。

研究设计与样本

  • 综述性文章,总结锰增强磁共振成像(MEMRI)的临床制剂开发、临床前研究及近期临床数据。

主要发现

  • 临床前研究证实MEMRI可定量心肌梗死、检测心肌存活并追踪心肌病中收缩力和钙处理改变。
  • 近期临床数据提示MEMRI在缺血性心肌病存活心肌定量和心肌钙处理异常早期检测中有潜力。

临床怎么用

  • MEMRI可作为互补方法用于缺血性心肌病存活心肌定量和心肌钙处理异常早期检测。

局限性

  • 锰的早期应用受其导致心肌抑制的潜力限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gadolinium-based contrast media are widely used in cardiovascular MRI to identify and to highlight the intravascular and extracellular space. After gadolinium, manganese has the second highest paramagnetic moment and was one of the first MRI contrast agents assessed in humans. Over the last 50 years, manganese-enhanced MRI (MEMRI) has emerged as a complementary approach enabling intracellular myocardial contrast imaging that can identify functional myocardium through its ability to act as a calcium analogue. Early progress was limited by its potential to cause myocardial depression. To overcome this problem, two clinical formulations of manganese were developed using either chelation (manganese dipyridoxyl diphosphate) or coadministration with a calcium compound (EVP1001-1, Eagle Vision Pharmaceuticals). Preclinical studies have demonstrated the efficacy of MEMRI in quantifying myocardial infarction and detecting myocardial viability as well as tracking altered contractility and calcium handling in cardiomyopathy. Recent clinical data suggest that MEMRI has exciting potential in the quantification of myocardial viability in ischaemic cardiomyopathy, the early detection of abnormalities in myocardial calcium handling, and ultimately, in the development of novel therapies for myocardial infarction or heart failure by actively quantifying viable myocardium. The stage is now set for wider clinical translational study of this novel and promising non-invasive imaging modality.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Spath NB, Thompson G, Baker AH, et al. Manganese-enhanced MRI of the myocardium. Heart. 2019. PMID: 31337670. doi:10.1136/heartjnl-2019-315227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。